ArticleBMC neurology2020
Highly active RRMS and ocrelizumab after failure of alemtuzumab therapy.
Martin Vališ et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ArticleBMC neurology2020
Martin Vališ et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.